Immunic Inc. buy tamam
Start price
25.03.20
/
50%
€7.50
Target price
04.11.21
€25.00
Performance (%)
17.93%
End price
05.11.21
€8.85
Summary
This prediction ended on 05.11.21 with a price of €8.85. The BUY prediction by tamam finished with a performance of 17.93%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immunic Inc. | -3.250% | -3.250% | -3.435% | -40.171% |
| iShares Core DAX® | -0,68 % | -4,85 % | 1,94 % | 54,33 % |
| iShares Nasdaq 100 | -0,03 % | 2,86 % | 18,90 % | 82,62 % |
| iShares Nikkei 225® | -0,54 % | -5,02 % | 28,15 % | 55,64 % |
| iShares S&P 500 | -0,21 % | 0,92 % | 13,69 % | 61,21 % |
Comments by tamam for this prediction
In the thread Immunic Inc. diskutieren
Immunic (NASDAQ:IMUX) announces positive top-line data from its phase 2 EMPhASIS trial of lead asset, IMU-838, the selective oral DHODH inhibitor, in patients with relapsing-remitting multiple sclerosis (RRMS).
In the thread Trading Immunic Inc.
Die von tamam gewählte maximale Laufzeit wurde überschritten